Corton Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-325
Closed -$201K 638
2024
Q3
$201K Buy
+325
New +$192K 0.1% 381
2024
Q2
Sell
-2,133
Closed -$1.24M 740
2024
Q1
$1.24M Sell
2,133
-1,557
-42% -$874K 0.46% 16
2023
Q4
$1.96M Buy
3,690
+1,475
+67% +$714K 0.62% 7
2023
Q3
$1.12M Buy
2,215
+449
+25% +$239K 0.57% 17
2023
Q2
$921K Buy
1,766
+513
+41% +$277K 0.43% 28
2023
Q1
$722K Buy
1,253
+164
+15% +$92.4K 0.5% 24
2022
Q4
$600K Sell
1,089
-349
-24% -$185K 0.49% 35
2022
Q3
$729K Sell
1,438
-676
-32% -$378K 0.89% 13
2022
Q2
$1.15M Sell
2,114
-106
-5% -$58.3K 1.08% 3
2022
Q1
$1.31M Buy
+2,220
New +$1.28M 0.57% 14

Other funds holding TMO

Corton Capital's TMO Position: Q4 2024 in Review

Corton Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 325 shares — an estimated $201K sold.

Corton Capital first reported a position in TMO in Q1 2022 and held it in 10 quarters. The position peaked at $1.96M in Q4 2023. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Corton Capital reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 325 Thermo Fisher Scientific shares in Q4 2024, an estimated $201K.
  • Corton Capital first reported a position in Thermo Fisher Scientific in Q1 2022 and held it in 10 quarters.
  • Corton Capital's Thermo Fisher Scientific position peaked at $1.96M in Q4 2023.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.